Infigratinib
Drug timelines are a Plus or Pro feature.
12 regulatory and trial events tracked for Infigratinib, covering 2022-06-27 to 2026-04-01. Get the full timeline:
Most recent: Clinical Trial Update: Interventional Study of Infigratinib in Children < 3 Years Old With Achondroplasia (ACH) [Phase 2]